PitchBook News - How PE keeps planes in the air

Plus: VC's medtech exits on the rise, energy storage gets funding boost, biopharma's high exit bar & more
Don't want to receive these emails? Manage your subscription.
PitchBook
Log in
The Weekend Pitch
August 25, 2024
The Daily Pitch is powered by PitchBook’s industry-defining research and best-in-class data
(Mara Potter/PitchBook News)
Private equity is doing its part to propel the return of planes to the sky.

With a resurgence in air travel and a lag in aircraft production, demand to sustain and refurbish older planes is fueling a rise in PE interest in the aerospace service and maintenance industry.

CORE Industrial Partners, a Chicago-based firm targeting the lower middle market, is one investor preparing to wager on this expected growth. It was founded by John May, who spent 18 years working on deals with institutions including Blackstone and HIG.

I'm Madeline Shi, and this is The Weekend Pitch. You can reach me at madeline.shi@pitchbook.com or on X @Madelin94615831.

In January, CORE acquired Florida-based Aviation Concepts, a provider of used serviceable materials to the aftermarket commercial aviation industry. May said the deal, which sets up the new platform company to consolidate the maintenance, repair and overhaul space, is a testament to the firm’s belief in the market’s long-term growth potential.
read more
 
Share: Email LinkedIn Twitter Facebook
 
A message from PitchBook Data  
2024 advertising opportunities with PitchBook
Clients trust PitchBook Media for top-tier ad placements in our seven specialized newsletters that connect with 2.1 million highly engaged PE and VC professionals. Backed by our robust global market data, we craft custom research reports and amplify clients' existing thought leadership through partnerships on PitchBook's asset class reports or native sponsored content columns.

Explore our Media Kit for more information or email us at mediasales@pitchbook.com.
Share: Email LinkedIn Twitter Facebook
 
 

Trivia

European VC valuations are on the mend, reports PitchBook's Leah Hodgson, with early-stage deals leading an uptick. Pre-seed in particular saw the largest rise in median pre-money valuations in the first half of 2024. What record figure did it reach?

A) €2.8 million
B) €3.7 million
C) €5.1 million
D) €4.4 million

Find your answer at the bottom of The Weekend Pitch!
 

Quote/Unquote

(Drew Sanders/PitchBook News)
"And I can tell you, [the auditors] go over it with a fine-tooth comb, asking
'why did you pick this? Why did you do this, do that?'"

—Ron Kahn, co-head of Lincoln International‘s portfolio valuation group, speaking to PitchBook reporter Jessica Hamlin on lingering distrust between LPs and their GPs.
 

Medtech exits test
a new venture

(Vithun Khamsong/Getty Images)
VC dealmaking in the medtech industry dipped in Q2, but activity is still on track to surpass last year and VC exits are on the rise, according to our latest Emerging Tech Research.

Startups generated $3.3 billion across 206 deals—declines of 7% and 3.3%, respectively, from the first quarter. Notable fundraises in Q2 included molecular testing provider BillionToOne raising a $130 million Series D and ultrasound device specialist Insightec securing $150 million.

PitchBook senior analyst Aaron DeGagne also highlights emerging opportunities in the heart arrhythmia and sepsis testing sectors.
 

From gravity to gas,
VC recharges energy storage

Companies working on alternatives to chemical batteries for energy storage received a funding boost in Q2.

Overall VC dealmaking in the clean energy market during the first half of the year was roughly in line with the same period in 2023. But the alternative energy storage sector surged in Q2 2024—notching over $582 million across 16 deals, according to our latest Emerging Tech Research.

Greater demand for renewable energy, including intermittent sources like solar and wind power, has increased the need for energy storage. The report highlights companies, like Highview Power, that are generating innovative solutions.
 

Biopharma startups face
a high bar for exits

(Andrew Brookes/Getty Images)
Biopharma remains a strong VC sector, showing resilience through funding rounds. But overall exit value has sharply declined quarter-over-quarter—from $10 billion in Q1 2024 to less than half that amount in Q2, according to our latest Emerging Tech Research.

Only biopharma companies with robust clinical data are succeeding in IPOs, leaving the majority of startups facing significant barriers to exit. This suggests many—particularly those focusing on gene editing, targeted cancer treatment and AI drug discovery platforms—may need to continue their development independently rather than seeking acquisition by Big Pharma.
 

Stay tuned

Keep an eye out for these insights and research reports coming out this week:
  • Q2 2024 Retail Fintech Report
  • Q2 2024 Enterprise SaaS Report
  • Analyst Note: The Rise of European Megafunds: Part II
  • Q2 2024 Public PE Roundup
  • Analyst Note: VC Returns by Series: Part IV
 

Trivia

Answer: D.

H1 2024 pre-seed dealmaking reached a €4.4 million median pre-money valuation, according to PitchBook News coverage. You can learn more about other trends and the overall picture in the Q2 2024 European VC Valuations Report.

This edition of The Weekend Pitch was written by Madeline Shi and Jacob Robbins. It was edited by Heather West and Clarinda Simpson.

Were you forwarded The Weekend Pitch? Sign up at pitchbook.com/subscribe.
 
Since yesterday, the PitchBook Platform added:
1
VC valuations
73
People
41
Companies
See what our data software can do
 
About PitchBook | Terms of use | Advertise with us | Contact
Follow us: in twtr fb

This email was sent to you via the PitchBook Platform.

Do you want to change your email address, get a different edition or unsubscribe? Manage your subscription here.

PitchBook Data Inc., 901 Fifth Avenue, Suite 1200, Seattle WA 98164, United States

© 2024 PitchBook. Win what's next. All rights reserved.

Older messages

Gene-editing and AI: Biopharma's future

Saturday, August 24, 2024

Also: A revival in retail fintech funding; The rise of PE megafunds in Europe; VC deal and exit activity on the rise in France; New medtech research. Don't want to receive these emails? Manage your

A high bar for biopharma exits

Friday, August 23, 2024

Are VC valuations cheaper than they look?; Carlyle, Advance Auto Parts swap Worldpac unit; PE fundraising rebounds in Asia Don't want to receive these emails? Manage your subscription. Log in The

VC recharges energy storage

Thursday, August 22, 2024

The 10 AI chipmakers pulling in the most VC cash; 6 charts: Europe's VC valuations; checking in on France's private markets Don't want to receive these emails? Manage your subscription. Log

A path to recovery for Europe's VC valuations

Wednesday, August 21, 2024

VC eyes opportunity in data observation; first-time healthcare investor jockeys for $850M; Fortera picks up $85M for low-carbon cement Don't want to receive these emails? Manage your subscription.

AI ripens farm management tech

Tuesday, August 20, 2024

Medtech exits on the mend; startups are running out of runway; mega-rounds drive femtech funding Don't want to receive these emails? Manage your subscription. Log in The Daily Pitch: VC August 20,

You Might Also Like

FREE AI training for marketers…

Thursday, September 19, 2024

Hi Reader, Do you know you need to do more with AI? If so, I've got some high-quality video training for you. It's designed by me. And for a limited time, it's free. GET ACCESS TODAY I can

Exciting announcement

Thursday, September 19, 2024

I've got an announcement just for you: Our master class series last year had a 99% satisfaction rate. Several people have emailed me asking for a repeat of the experience this year... So, we're

📣 Now open: free registration for Litmus Live, SEO for email, and more

Thursday, September 19, 2024

The latest email resources from the Litmus blog and a few of our favorite things from around the web last week. ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌ ͏‌

Discover the new Digiday Streaming and Video Awards categories

Thursday, September 19, 2024

Showcase how your company is modernizing streaming and video ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Fed Begins Easing Cycle with Jumbo 50bps Rate Cut

Thursday, September 19, 2024

Plus House Committee Questions SEC's Crypto Strategy in Divisive Hearing ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

[Webinar] 👀 Unlock lululemon’s winning social media formula

Thursday, September 19, 2024

Join us for an exclusive peek on October 1! ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

🦄 The GTM coach for 12 unicorns

Thursday, September 19, 2024

An interview with Scott Leese, Founder and CEO of Scott Leese Consulting. 🤝 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

✅ The Forbes Parasite SEO Playbook

Thursday, September 19, 2024

GM nerds, Welcome back to the newsletter that makes it make sense: ​ TLDR; favoritism, corruption, incompetence, etc. More on this later, but here's what's good this week: → Meta's New AI-

HubSpot and Shopify Are Both Going More Enterprise

Thursday, September 19, 2024

But Also — More SMB. To view this email as a web page, click here saastr daily newsletter HubSpot and Shopify Are Both Going More Enterprise. But Also — More SMB. By Jason Lemkin Tuesday, September 17,

How Flodesk bootstrapped to $27,000,000

Thursday, September 19, 2024

Let's break down how Flodesk scaled their SaaS business! ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌